Figure 2From: Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL)Kaplan-Meier survival analysis of primary adrenal DLBCL treated with R-CHOP. Overall survival (A) and progression-free survival (B) of 31 patients with primary adrenal DLBCL. Overall survival (C) and progression-free survival (D) according to the response of R-CHOP.Back to article page